cancer-drive-gene-mutations-detection Videos
8 videos found
When you talk about cancer, there are good news and there are bad news. The bad news is that population-based early cancer detection does not work – yet. Every day, almost 50,000 people are diagnosed with the disease, and more than 26,000 die. ...
Apr. 28, 2022
Ovarian cancer detection with eNose PEN3 Airsense ...
Jan. 25, 2021
Focal Healthcare created Fusion Bx to make prostate cancer detection accurate, efficient and ...
Nov. 18, 2022
CEO Dr. Gene Cartwright of Guided Therapeutics, Inc. (OTCQB: GTHP), joins Stock Day to talk about their rapid and painless cervical cancer detection testing device LuViva and the international market for ...
Aug. 17, 2021
A explanation of our products for Fast Mohs IHC, followed by a demonstration of the Fast Mohs technique on our Bio SB TintoDetector ImmunoDNA manual staining system. Featuring our selection of TintoFast antibodies, and detection systems for fast IHC cancer detection after Mohs surgery. Bio SB’s Fast Mohs IHC products are a selection of antibodies and detection systems for fast IHC cancer ...
Oct. 17, 2022
Leveraging the power of Artificial Intelligence (AI) CureMetrix is committed to advancing technology that improves disease detection and cancer survival rates across the globe. We believe that providing radiologists with the most advanced technology to support their evaluation of mammograms will support improved clinical and financial outcomes along with increased assurance for imaging centers, ...
May. 27, 2021
1 out 7 Canadian men are diagnosed with Prostrate Cancer each year. We cannot emphasize enough on how important it is to get tested each year. Nanostics Inc has come up with a non-invasive diagnostic test to bring clarity to healthcare decisions. Their core technology is in development to be able to diagnose Prostrate Cancer from a simple blood sample. To learn more about this research click on ...
Jan. 3, 2023
OTraces has developed a patented technology to enhance the accuracy of cancer detection and surveillance with a simple blood test, currently for prostate cancer and breast cancer. Going beyond the current liquid biopsy technology, OTraces' blood test s biomarker agnostic and utilizes ordinary ELISA instrumentation. It is the first test to achieve access to active proteins found in the tumor ...
May. 21, 2021